Best for Pregnancy
Best DHA for Pregnancy
Top 1 products ranked · Reviewed May 2026 · 250–1000 mg clinical dose
Why DHA for Pregnancy
DHA plays a important role in pregnancy. DHA is the primary structural omega-3 in the brain (~97% of brain omega-3s) and retina (~93% of retinal omega-3s). Critical during pregnancy for fetal brain development — minimum 200-300mg DHA recommended.
What dose to look for
Clinical studies typically use 250–1000 mg of dha. 250mg minimum for vision/brain maintenance; 500-1000mg for cognitive outcomes. Products below this range may not deliver meaningful results.
What the research says
DHA has strong clinical evidence for pregnancy benefits. DHA constitutes ~97% of brain omega-3s. RCTs confirm benefits for cognitive function, visual acuity, and fetal neurodevelopment. Learn more
Clinical research on Omega-3 Fatty Acids (DHA/EPA)
MODERATE — decent preterm-birth signal; cognition claims weaker and largely null in fish-replete mothers · ≥200 mg/day DHA in pregnancy and lactation (ACOG/AAP floor); prefer algal DHA over fish oil to avoid methylmercury. DHA is the pregnancy-relevant fraction; EPA contributes little here
- •DOMInO (largest prenatal DHA RCT): 800 mg/day DHA did not improve infant Bayley cognitive scores at 18 months — and stayed null at 4- and 7-year follow-up. A secondary signal of fewer very-low-birthweight births. PubMed
- •ORIP (largest single preterm-birth trial): 900 mg/day DHA-dominant n-3 did not reduce early preterm birth (<34 weeks) at the population level, with only a subgroup signal in women with low baseline n-3 status. PubMed
- •KUDOS: 600 mg/day algal DHA modestly increased gestational length (~2.9 days) and birth size; later cognitive endpoints were largely null. Birth-outcome effects were the cleanest signal. (Industry-funded.) PubMed
- •DHA is the pregnancy-relevant fraction — it accretes in fetal brain and retina, fastest in the third trimester. EPA is the cardiovascular/mood fraction with no distinct prenatal role, so pregnancy formulas should be DHA-led.
- •Honest read: the mechanism is solid but RCT effect sizes are small in fish-replete populations; the strongest case is mothers with very low fish intake. Marketing implying clear infant-IQ gains overstates what the controlled trials deliver.
